



Nicholas Pirmal acquires Avecia Pharmacueitcals in UKPosted AtExpressPharmaPulse.comNicholas Piramal India (NPIL) announced
the acquisition of Avecia Pharmaceuticals, UK for a
consideration of Ã,£9.5 million. The consideration
is inclusive of funding the business' UK pension fund
deficit of between Ã,£8-9 million. The transaction
completion is subject to required regulatory and other
approvals. November 23, 2005
|